Share-Based Compensation - Summary of Company's Stock Option Plan Activity (Details) - Employee Stock Option - USD ($) |
3 Months Ended | 6 Months Ended | 12 Months Ended | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Jun. 30, 2026 |
Mar. 31, 2026 |
Jun. 30, 2025 |
Mar. 31, 2025 |
Jun. 30, 2026 |
Jun. 30, 2025 |
Dec. 31, 2025 |
Dec. 31, 2024 |
|||||||
| Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] | ||||||||||||||
| Stock options, beginning balance | 6,350,000 | 6,350,000 | 6,350,000 | 6,350,000 | 6,350,000 | 6,350,000 | 6,350,000 | |||||||
| Granted, in shares | 0 | 0 | ||||||||||||
| Exercised, in shares | 0 | 0 | ||||||||||||
| Forfeited, in shares | 0 | 0 | ||||||||||||
| Stock options, ending balance | 6,350,000 | 6,350,000 | 6,350,000 | 6,350,000 | 6,350,000 | 6,350,000 | 6,350,000 | 6,350,000 | ||||||
| Exercisable, in shares | 6,350,000 | [1] | 6,350,000 | 6,350,000 | [1] | 6,350,000 | ||||||||
| Outstanding, Beginning Balance, Weighted Average Exercise Price | $ 23 | $ 23 | $ 23 | $ 23 | $ 23 | $ 23 | ||||||||
| Outstanding, Ending Balance, Weighted Average Exercise Price | 23 | $ 23 | $ 23 | 23 | 23 | $ 23 | $ 23 | |||||||
| Exercisable, weighted-average exercise price | $ 23 | [1] | $ 23 | $ 23 | [1] | $ 23 | ||||||||
| Stock options, contractual term | 5 years 6 months | 6 years 6 months | 5 years 3 months | 6 years 3 months | 5 years 9 months | 6 years 9 months | ||||||||
| Exercisable, Weighted-Average Remaining Contractual Term | 5 years 3 months | [1] | 6 years 3 months | |||||||||||
| Options, aggregate intrinsic value | [2] | $ 0 | $ 0 | $ 0 | $ 0 | $ 0 | $ 0 | $ 7,938 | $ 0 | |||||
| Exercise intrinsic value | [2] | $ 0 | [1] | $ 0 | $ 0 | [1] | $ 0 | |||||||
| ||||||||||||||
| X | ||||||||||
- Definition The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The number of shares into which fully or partially vested stock options outstanding as of the balance sheet date can be currently converted under the option plan. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The weighted-average price as of the balance sheet date at which grantees can acquire the shares reserved for issuance on vested portions of options outstanding and currently exercisable under the stock option plan. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount by which the current fair value of the underlying stock exceeds the exercise price of options outstanding. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of options outstanding, including both vested and non-vested options. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Amount of difference between fair value of the underlying shares reserved for issuance and exercise price of vested portions of options outstanding and currently exercisable. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Weighted-average contractual term remaining for vested portion of option outstanding and currently exercisable or convertible, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Weighted-average contractual term remaining for option award outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of share options (or share units) exercised during the current period. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Details
|